SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-208865
Filing Date
2020-08-04
Accepted
2020-08-04 09:15:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d646578ds3.htm S-3 538635
2 EX-1.2 d646578dex12.htm EX-1.2 183666
3 EX-4.3 d646578dex43.htm EX-4.3 306817
4 EX-4.4 d646578dex44.htm EX-4.4 311950
5 EX-5.1 d646578dex51.htm EX-5.1 15372
6 EX-23.1 d646578dex231.htm EX-23.1 1424
7 GRAPHIC g646578dsp71.jpg GRAPHIC 3067
8 GRAPHIC g646578g03y57.jpg GRAPHIC 49576
9 GRAPHIC g646578g63b17.jpg GRAPHIC 49192
  Complete submission text file 0001193125-20-208865.txt   1487159
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-240323 | Film No.: 201071404
SIC: 2836 Biological Products, (No Diagnostic Substances)